No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs562290969 |
chr6:165722680-165722681 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs377546919 |
chr6:165722735-165722736 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs529556680 |
chr6:165722764-165722765 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs377085936 |
chr6:165722773-165722774 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs562957721 |
chr6:165722779-165722780 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs530467305 |
chr6:165722789-165722790 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs112324018 |
chr6:165722790-165722791 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs62442133 |
chr6:165722802-165722803 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs192479037 |
chr6:165722810-165722811 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs550843 |
chr6:165722832-165722833 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs546493745 |
chr6:165722833-165722834 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs568234769 |
chr6:165722842-165722843 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs374603171 |
chr6:165722843-165722844 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs557252901 |
chr6:165722892-165722893 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs569164312 |
chr6:165722900-165722901 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs539887408 |
chr6:165722944-165722945 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs9459360 |
chr6:165722945-165722946 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs573288481 |
chr6:165722975-165722976 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs184518240 |
chr6:165722998-165722999 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs371642796 |
chr6:165723036-165723037 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs200159427 |
chr6:165723063-165723064 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs147652862 |
chr6:165723066-165723067 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs200439062 |
chr6:165723096-165723097 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs373359871 |
chr6:165723103-165723104 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs547779815 |
chr6:165723130-165723131 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs377157909 |
chr6:165723133-165723134 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs566091294 |
chr6:165723155-165723156 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs575424 |
chr6:165723166-165723167 |
Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs555168433 |
chr6:165723210-165723211 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs564077372 |
chr6:165723241-165723242 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs542358743 |
chr6:165723263-165723264 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs71688984 |
chr6:165723264-165723265 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs528197917 |
chr6:165723292-165723293 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs546628813 |
chr6:165723345-165723346 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs190203579 |
chr6:165723352-165723353 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs529142271 |
chr6:165723360-165723361 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs147851069 |
chr6:165723442-165723443 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs578066 |
chr6:165723449-165723450 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs368223684 |
chr6:165723472-165723473 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs621122 |
chr6:165723485-165723486 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs182478454 |
chr6:165723508-165723509 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs185742396 |
chr6:165723517-165723518 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs573635427 |
chr6:165723532-165723533 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs140291254 |
chr6:165723537-165723538 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs537677585 |
chr6:165723556-165723557 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs386708347 |
chr6:165723559-165723560 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs508897 |
chr6:165723568-165723569 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs573795856 |
chr6:165723653-165723654 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs508041 |
chr6:165723655-165723656 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs374075131 |
chr6:165723707-165723708 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|